The Advisory Committee is an esteemed group of industry thought leaders assembled by BIO to shape this event’s conference program by collaboratively identifying topics and speakers that will facilitate engaging and informative discussions.
Thank you to our 2024 Advisory Committee

Lindsay Androski
President and CEO, Roivant Social Ventures
President and CEO, Roivant Social Ventures

Gad Berdugo
Founder and Managing Partner, Explorium Capital LLC
Founder and Managing Partner, Explorium Capital LLC

Michelle Doig
Partner, Head of Corporate Development, Omega Funds
Partner, Head of Corporate Development, Omega Funds

Chris Garabedian
Chairman & CEO, Xontogeny
Chairman & CEO, Xontogeny

Kate Haviland
CEO, Blueprint Medicines
CEO, Blueprint Medicines

Jennifer Hawks Bland
CEO, NewYorkBIO
CEO, NewYorkBIO

Darren Ji, MD, PhD, MBA
Co-Founder, Chairman, Chief Executive Officer, Elpiscience

Anna Kazanchyan, MD
Founder and CEO, Saghmos Therapeutics
Founder and CEO, Saghmos Therapeutics

Evan Loh, MD
CEO, Paratek
CEO, Paratek

Glennis Mehra, PhD
Director, BioLabs New York
Director, BioLabs New York

Kimberly Nearing
Venture Partner, BVCF
Venture Partner, BVCF

Stephen M. Ritoch
Chairman and CEO, Blaise Group International, Inc.
Chairman and CEO, Blaise Group International, Inc.

Philip Ross
Global Chairman, Healthcare Investment Banking, J.P. Morgan
Global Chairman, Healthcare Investment Banking, J.P. Morgan

Jennifer Sheng
Managing Director, Healthcare Equity Capital Markets, Citigroup Global Markets
Managing Director, Healthcare Equity Capital Markets, Citigroup Global Markets

Michael Ward
Vice President, Public Policy, Alliance for Aging Research
Vice President, Public Policy, Alliance for Aging Research

Alethia Young
CFO, Bicycle Therapeutics
CFO, Bicycle Therapeutics